We are live on ! Find out more
RCW

Rheos Capital Works Portfolio holdings

AUM $1.5B
1-Year Est. Return 47.78%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+47.78%
3 Year Est. Return
+159.74%
5 Year Est. Return
+203.98%
10 Year Est. Return
AUM
$1.23B
AUM Growth
-$577M
Cap. Flow
-$525M
Cap. Flow %
-42.79%
Top 10 Hldgs %
37.56%
Holding
102
New
5
Increased
20
Reduced
21
Closed
35

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$54M
2
BABA icon
Alibaba
BABA
+$29.8M
3
DIS icon
Walt Disney
DIS
+$26.4M
4
COST icon
Costco
COST
+$25.7M
5
CNH
CNH Industrial
CNH
+$25.5M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$148M
2
V icon
Visa
V
+$63.2M
3
NVDA icon
NVIDIA
NVDA
+$49.1M
4
C icon
Citigroup
C
+$39.4M
5
MSI icon
Motorola Solutions
MSI
+$36.7M

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Consumer Discretionary 19.77%
3 Industrials 17.47%
4 Consumer Staples 10.77%
5 Communication Services 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
26
Baker Hughes
BKR
$62.3B
$17.1M 1.4%
+390,000
New +$17.4M
LULU icon
27
lululemon athletica
LULU
$14.2B
$15.7M 1.28%
55,500
DAR icon
28
Darling Ingredients
DAR
$9.62B
$15.6M 1.27%
500,000
KEY icon
29
KeyCorp
KEY
$24.3B
$15.3M 1.25%
960,000
+360,000
+60% +$6.11M
LMT icon
30
Lockheed Martin
LMT
$135B
$15.3M 1.24%
34,200
+10,000
+41% +$4.6M
CCI icon
31
Crown Castle
CCI
$31.9B
$15.1M 1.23%
145,000
MU icon
32
Micron Technology
MU
$996B
$14.7M 1.2%
169,000
+40,000
+31% +$3.84M
XYL icon
33
Xylem
XYL
$28.2B
$14.4M 1.18%
120,900
MDGL icon
34
Madrigal Pharmaceuticals
MDGL
$11.8B
$14.3M 1.17%
43,215
-13,000
-23% -$4.27M
LHX icon
35
L3Harris
LHX
$53.9B
$14.1M 1.15%
67,300
+30,000
+80% +$6.29M
BX icon
36
Blackstone
BX
$107B
$13.9M 1.13%
99,500
-6,500
-6% -$1.06M
PANW icon
37
Palo Alto Networks
PANW
$293B
$13.7M 1.11%
80,200
-28,000
-26% -$5.18M
A icon
38
Agilent Technologies
A
$39.9B
$11.6M 0.95%
99,200
AKRO
39
DELISTED
Akero Therapeutics
AKRO
$11.2M 0.91%
276,000
ELV icon
40
Elevance Health
ELV
$84.9B
$10.9M 0.89%
25,000
+15,000
+150% +$6.02M
SCI icon
41
Service Corp International
SCI
$11.6B
$10.8M 0.88%
135,000
C icon
42
Citigroup
C
$224B
$10.4M 0.85%
146,500
-517,000
-78% -$39.4M
SNPS icon
43
Synopsys
SNPS
$77.7B
$10.3M 0.84%
24,000
-25,000
-51% -$12.1M
BJ icon
44
BJs Wholesale Club
BJ
$12.4B
$10.2M 0.83%
89,000
-40,000
-31% -$4.12M
AXP icon
45
American Express
AXP
$231B
$9.87M 0.8%
36,700
-78,500
-68% -$23.2M
HLI icon
46
Houlihan Lokey
HLI
$8.92B
$9.76M 0.79%
60,400
-13,000
-18% -$2.23M
BA icon
47
Boeing
BA
$184B
$9.62M 0.78%
56,400
+30,000
+114% +$5.19M
NTNX icon
48
Nutanix
NTNX
$16.3B
$9.21M 0.75%
132,000
BAH icon
49
Booz Allen Hamilton
BAH
$8.89B
$8.89M 0.72%
+85,000
New +$10.2M
MEDP icon
50
Medpace
MEDP
$16.3B
$8.87M 0.72%
29,101

Similar funds

Rheos Capital Works's Q1 2025 Portfolio in Review

As of Q1 2025, Rheos Capital Works held 102 positions worth $1.23B, down 32% from $1.8B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rheos Capital Works withdrew a net $525M in Q1 2025, closing 35 positions and reducing 21 holdings. Its most notable exit was Visa, an estimated $63.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Rheos Capital Works opened a new position in CNH Industrial worth $24.9M.

  • Rheos Capital Works's largest Q1 2025 buy was CNH Industrial: 2,030,000 shares worth $24.9M.
  • Rheos Capital Works added most to TJX Companies in Q1 2025, an estimated $54M increase.
  • Rheos Capital Works's biggest Q1 2025 reduction was Goldman Sachs, cutting an estimated $148M.
  • Rheos Capital Works fully exited Visa in Q1 2025, selling an estimated $63.2M.
  • Rheos Capital Works's ten largest holdings make up 38% of its $1.23B portfolio in Q1 2025.
  • Rheos Capital Works opened 5 new positions and closed 35 in Q1 2025.
  • Rheos Capital Works's portfolio value fell 32% quarter-over-quarter to $1.23B.

Based on Rheos Capital Works's 13F filing for Q1 2025, filed 14 Apr 2025.